Anschlarin
Anschlarin Uses, Dosage, Side Effects, Food Interaction and all others data.
A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Anschlarin is used to build up the blood in anemia.
The major activity of supplemental iron is in the prevention and treatment of iron deficiency anemia. Anschlarin has putative immune-enhancing, anticarcinogenic and cognition-enhancing activities.
| Trade Name | Anschlarin |
| Availability | Prescription only |
| Generic | Iron |
| Iron Other Names | Eisen, Iron powder, Reduced iron |
| Related Drugs | ferrous sulfate, Venofer, Auryxia |
| Type | |
| Formula | Fe |
| Weight | Average: 55.845 Monoisotopic: 55.934942133 |
| Groups | Approved |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Anschlarin is an essential element commonly used for the treatment of patients with documented iron deficiency.
Used in preventing and treating iron-deficiency anemia.
Anschlarin is also used to associated treatment for these conditions: Anemia, Iron Deficiency (ID), Iron Deficiency Anemia (IDA), Restless Legs Syndrome (RLS), Concomitant myelosuppressive chemotherapy, Nutritional supplementation, Dietary supplementation
How Anschlarin works
Anschlarin is necessary for the production of hemoglobin. Anschlarin-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.
Toxicity
Acute iron overdosage can be divided into four stages. In the first stage, which occurs up to six hours after ingestion, the principal symptoms are vomiting and diarrhea. Other symptoms include hypotension, tachycardia and CNS depression ranging from lethargy to coma. The second phase may occur at 6-24 hours after ingestion and is characterized by a temporary remission. In the third phase, gastrointestinal symptoms recur accompanied by shock, metabolic acidosis, coma, hepatic necrosis and jaundice, hypoglycemia, renal failure and pulmonary edema. The fourth phase may occur several weeks after ingestion and is characterized by gastrointestinal obstruction and liver damage. In a young child, 75 milligrams per kilogram is considered extremely dangerous. A dose of 30 milligrams per kilogram can lead to symptoms of toxicity. Estimates of a lethal dosage range from 180 milligrams per kilogram and upwards. A peak serum iron concentration of five micrograms or more per ml is associated with moderate to severe poisoning in many.
Food Interaction
- Take with or without food. Many different products contain iron; refer to the product monograph for more specific instruction. Taking iron with food may reduce gastric irritation.
Anschlarin Disease Interaction
Elimination Route
The efficiency of absorption depends on the salt form, the amount administered, the dosing regimen and the size of iron stores. Subjects with normal iron stores absorb 10% to 35% of an iron dose. Those who are iron deficient may absorb up to 95% of an iron dose.
Innovators Monograph
You find simplified version here Anschlarin
